Source: Bloomberg Technology · Category: AI Use Cases & Ideas
Insilico Medicine is applying AI to drug discovery and longevity research. This is a concrete application of AI to high-stakes, regulated R&D. Your pharma and biotech clients facing discovery timelines and cost pressures could pilot similar AI-augmented workflows—consider which therapeutic areas or screening stages are ripe for AI acceleration.
Source: Bloomberg Technology · Category: AI Products & Releases OpenAI shut down Sora, its video-generation tool, forcing the AI film 'Critterz' to miss Cannes. This signals OpenAI is restricting or sunsetting capabilities—potentially due to safety, copyright, or commercial strategy. Track Sora's future: clients investing in AI
Source: MIT Technology Review AI · Category: AI Research & Breakthroughs Demis Hassabis at Google I/O proclaimed AI is 'standing in the foothills of the singularity,' signaling DeepMind's framing of near-term AI science breakthroughs as steps toward transformative capability. This is rhetorical positioning ahead of major
Source: Bloomberg Technology · Category: Enterprise AI Adoption Kawasaki Heavy Industries is partnering with Nvidia on physical AI robots, triggering a 12% stock rally. This demonstrates enterprise momentum in embodied AI and robotics. For clients in manufacturing, logistics, or field services, this validates the case for pilot programs in robotic process
Source: Bloomberg Technology · Category: AI Regulation & Policy The EU and Anthropic are in stalled negotiations over Anthropic's Mythos AI model and its ability to uncover digital vulnerabilities in EU financial institutions. This reflects broader EU tension over frontier-lab control and transparency. Impact: expect continued friction on EU-US